End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Chart calendar Sarepta Therapeutics Inc
Upcoming events on Sarepta Therapeutics Inc
Past events on Sarepta Therapeutics Inc
2024-03-12 03:05 pm | Barclays Global Healthcare Conference |
2024-03-11 10:00 am | Leerink Partners Global Biopharma Conference |
2024-02-28 04:30 pm | Q4 2023 Earnings Call |
2024-02-28 04:05 pm | Q4 2023 Earnings Release |
2024-01-29 08:30 am | SRP-5051-201 Phase 2 Part B Study Results Call |
2024-01-29 08:30 am | SRP-5051-201 Phase 2 Part B Study Results Call |
2024-01-08 12:00 pm | JPMorgan Healthcare Conference |
2023-11-09 09:00 am | UBS BioPharma Conference |
2023-11-01 04:30 pm | Q3 2023 Earnings Call |
2023-11-01 04:05 pm | Q3 2023 Earnings Release |
2023-10-30 04:30 pm | Business Update Call |
2023-09-11 08:40 am | Morgan Stanley Global Healthcare Conference |
2023-08-02 04:30 pm | Q2 2023 Earnings Call |
2023-08-02 04:05 pm | Q2 2023 Earnings Release |
2023-07-10 11:00 am | Cowen RNA Therapeutics Summit |
2023-06-22 04:30 pm | ELEVIDYS FDA Approval Call |
2023-06-08 10:00 am | Annual General Meeting |
2023-05-02 04:30 pm | Q1 2023 Earnings Call |
2023-05-02 04:05 pm | Q1 2023 Earnings Release |
2023-03-16 04:30 pm | SRP-9001 BLA Update Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 381 379 0.54% | 540 537 0.61% | 702 689 1.8% | 933 925 0.86% | 1 243 1 233 0.87% | 1 821 |
EBITDA Million USD | Released Forecast Spread | -681 -596 -14.33% | -537 -535 -0.4% | -422 -479 11.97% | -494 -518 4.49% | 0,00 -278 - | 193 |
EBIT Million USD | Released Forecast Spread | -706 -611 -15.49% | -564 -518 -8.89% | -460 -460 -0.03% | -536 -517 -3.66% | -268 -303 11.68% | 202 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -714 -618 -15.52% | -553 -522 -6% | -419 -433 3.28% | -690 -708 2.57% | -520 -559 6.94% | 207 |
Net income Million USD | Released Forecast Spread | -715 -617 -15.85% | -554 -519 -6.72% | -419 -438 4.35% | -703 -677 -3.95% | -536 -579 7.41% | 222 |
EPS USD | Released Forecast Spread | -9,71 -8,44 -15.05% | -7,11 -6,66 -6.71% | -5,15 -5,20 0.98% | -8,03 -7,54 -6.49% | -5,80 -6,39 9.19% | 2,52 |
Announcement Date | 26/02/20 | 01/03/21 | 01/03/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 201 198 1.53% | 211 208 1.24% | 233 221 5.56% | 230 235 -1.83% | 258 251 3.16% | 254 241 4.98% | 261 262 -0.36% | 332 287 15.71% | 397 386 2.75% | 375 | 392 | 494 | 576 | 749 |
EBIT Million USD | Released Forecast Spread | -106 -99,6 -6.2% | -86,9 -109 20.02% | -211 -92,7 -127.71% | -131 -112 -17.53% | -107 -105 -1.92% | -138 -116 -19.22% | -134 -169 21.04% | -20,8 -120 82.64% | 24,6 -7,43 431.59% | -18,4 | -17,5 | 79,4 | 146 | 283 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -122 -106 -15.45% | -104 -115 9.58% | -228 -99,6 -128.92% | -256 -132 -93.89% | -101 -115 11.92% | -513 -129 -298.57% | -14,6 -156 90.67% | -33,2 -105 68.47% | 40,4 4,23 854.54% | -9,95 | -7,90 | 83,7 | 148 | 286 |
Net income Million USD | Released Forecast Spread | -122 -114 -6.91% | -105 -118 10.76% | -231 -101 -129.34% | -258 -122 -111.7% | -109 -103 -6.06% | -517 -116 -343.89% | -23,9 -164 85.42% | -40,9 -115 64.4% | 45,7 -5,49 931.45% | -4,23 | 2,64 | 86,8 | 144 | 283 |
EPS USD | Released Forecast Spread | -1,42 -1,22 -16.65% | -1,20 -1,35 11.25% | -2,65 -1,15 -130.76% | -2,94 -1,41 -109.25% | -1,24 -1,18 -5.21% | -5,86 -1,29 -353.43% | -0,27 -1,80 85.01% | -0,46 -1,26 63.38% | 0,47 -0,05 1083.47% | 0,00 | 0,01 | 0,82 | 1,52 | 3,76 |
Announcement Date | 01/03/22 | 04/05/22 | 02/08/22 | 02/11/22 | 28/02/23 | 02/05/23 | 02/08/23 | 01/11/23 | 28/02/24 | - | - | - | - | - |
Past sector events for Sarepta Therapeutics Inc
Today | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
2024-03-27 07:00 am | ALTIMMUNE, INC.: Q4 2023 Earnings Release |
2024-03-26 | LEPU BIOPHARMA CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 | REMEGEN CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 | PHILOGEN S.P.A.: Q4 2023 Earnings Release |
2024-03-26 | ASCENTAGE PHARMA GROUP INTERNATIONAL: Q4 2023 Earnings Release |
2024-03-26 01:16 pm | KEYMED BIOSCIENCES INC.: Q4 2023 Earnings Release |
2024-03-24 | IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.: Q4 2023 Earnings Release |
2024-03-24 | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-03-21 04:01 pm | DIANTHUS THERAPEUTICS, INC.: Q4 2023 Earnings Release |
- Stock
- Equities
- Stock Sarepta Therapeutics, Inc.
- Stock Sarepta Therapeutics Inc - Nasdaq
- Calendar Sarepta Therapeutics Inc